Ilka Schellschmidt Selected Research

drospirenone and ethinyl estradiol combination (Yasmin)

1/2006	The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.
8/2004	Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilka Schellschmidt Research Topics

Disease

2	Hemorrhage 03/2012 - 01/2006
2	Acne Vulgaris 04/2009 - 08/2004
1	Pain (Aches) 03/2012
1	Azoospermia 02/2002
1	Body Weight (Weight, Body) 02/2002

Drug/Important Bio-Agent (IBA)

2	Contraceptive Agents (Contraceptives)IBA 03/2012 - 08/2004
2	Progestins (Progestagens)IBA 04/2009 - 02/2002
2	Combined Oral ContraceptivesIBA 04/2009 - 08/2004
2	AndrogensIBA 04/2009 - 08/2004
2	drospirenone and ethinyl estradiol combination (Yasmin)FDA LinkGeneric 01/2006 - 08/2004
2	drospirenone FDA LinkGeneric 01/2006 - 08/2004
1	Levonorgestrel (Plan B)FDA LinkGeneric 03/2012
1	Cyproterone AcetateIBA 04/2009
1	dienogest FDA Link 04/2009
1	Oral ContraceptivesIBA 01/2006
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 08/2004
1	Therapeutic UsesIBA 08/2004
1	ethinyl estradiol drug combination norgestimate (Ortho Tri-Cyclen)FDA LinkGeneric 08/2004
1	Sex Hormone-Binding GlobulinIBA 08/2004
1	norgestimate FDA LinkGeneric 08/2004
1	Alkaline PhosphataseIBA 02/2002
1	EnzymesIBA 02/2002
1	GonadotropinsIBA 02/2002
1	Hemoglobins (Hemoglobin)IBA 02/2002
1	HDL CholesterolIBA 02/2002

Therapy/Procedure

3	Contraception (Birth Control) 03/2012 - 02/2002